Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · IEX Real-Time Price · USD
11.04
-0.32 (-2.82%)
At close: Apr 25, 2024, 4:00 PM
10.85
-0.19 (-1.72%)
After-hours: Apr 25, 2024, 4:43 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $547.93 million as of April 25, 2024. Its market cap has decreased by -1.54% in one year.
Market Cap
547.93M
Enterprise Value
311.36M
1-Year Change
-1.54%
Ranking
Category
Stock Price
$11.04
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has decreased from $624.91M to $547.93M, a decrease of -12.32%. That is a compound annual growth rate of -10.35%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 563.80M | -0.62% |
Apr 23, 2024 | 567.30M | 2.60% |
Apr 22, 2024 | 552.90M | -1.32% |
Apr 19, 2024 | 560.30M | 5.02% |
Apr 18, 2024 | 533.50M | -10.43% |
Apr 17, 2024 | 595.60M | -0.57% |
Apr 16, 2024 | 599.00M | -2.19% |
Apr 15, 2024 | 612.40M | -5.16% |
Apr 12, 2024 | 645.70M | -0.77% |
Apr 11, 2024 | 650.70M | 2.10% |
Apr 10, 2024 | 637.30M | -2.28% |
Apr 9, 2024 | 652.20M | -0.90% |
Apr 8, 2024 | 658.10M | 2.08% |
Apr 5, 2024 | 644.70M | 3.02% |
Apr 4, 2024 | 625.80M | -2.25% |
Apr 3, 2024 | 640.20M | 2.53% |
Apr 2, 2024 | 624.40M | -3.45% |
Apr 1, 2024 | 646.70M | 0.94% |
Mar 28, 2024 | 640.70M | 1.01% |
Mar 27, 2024 | 634.30M | -0.47% |
Mar 26, 2024 | 637.30M | -0.61% |
Mar 25, 2024 | 641.20M | 0.61% |
Mar 22, 2024 | 637.30M | -1.91% |
Mar 21, 2024 | 649.70M | 18.04% |
Mar 20, 2024 | 550.40M | -0.67% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Lyell Immunopharma | 584.42M |
Novavax | 580.80M |
Nuvation Bio | 580.00M |
GH Research | 576.47M |
Olema Pharmaceuticals | 567.53M |
Prime Medicine | 563.71M |
CureVac | 561.95M |
Jin Medical International | 552.61M |